Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis

• Main Authors: Yingying Yang (Author), Lu Ding (Author), Tingting Bao (Author), Yaxin Li (Author), Jing Ma (Author), Qingwei Li (Author), Zezheng Gao (Author), Siyu Song (Author), Jing Wang (Author), Jiachao Zhao (Author), Ziyuan Wang (Author), Daqing Zhao (Author), Xiangyan Li (Author), Zeyu Wang (Author), Linhua Zhao (Author), Xiaolin Tong (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pulmonary fibrosis (PF) is one of the pathologic changes in COVID-19 patients in convalescence, and it is also a potential long-term sequela in severe COVID-19 patients. Qimai Feiluoping decoction (QM) is a traditional Chinese medicine formula recommended in the Chinese national medical program for...